本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

135.91
-5.4600-3.86%
成交量:63.48万
成交额:8,694.80万
市值:138.63亿
市盈率:19.92
高:139.60
开:139.60
低:135.65
收:141.37
52周最高:186.12
52周最低:122.14
股本:1.02亿
流通股本:9,999.56万
量比:0.90
换手率:0.63%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
净资产收益率:22.09%
总资产收益率:11.70%
市净率:3.75
市盈率(LYR):29.10

数据加载中...

2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31

重要事件披露

Form 8-K - Current report